Published in Circulation on December 19, 2013
Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol (2016) 1.41
Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention. Korean Circ J (2016) 0.82
The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One (2014) 0.75
Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol (2004) 3.74
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol (2005) 2.42
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J (2009) 2.19
Is surgery always mandatory for type A aortic dissection? Ann Thorac Surg (2006) 2.12
Coronary flow characteristics after a Bentall procedure with or without sinuses of Valsalva. Eur J Cardiothorac Surg (2004) 2.09
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. Catheter Cardiovasc Interv (2011) 2.03
Eosinophil cationic protein and clinical outcome after bare metal stent implantation. Atherosclerosis (2010) 1.98
Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. Circ Cardiovasc Interv (2014) 1.97
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. Circ Cardiovasc Interv (2012) 1.89
Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention (2012) 1.85
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J (2005) 1.74
Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol (2011) 1.73
Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med (2006) 1.73
Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J (2003) 1.70
Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol (2006) 1.64
Composite Y internal thoracic artery-saphenous vein grafts: short-term angiographic results and vasoreactive profile. J Thorac Cardiovasc Surg (2004) 1.57
Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study. JACC Cardiovasc Interv (2010) 1.54
Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations. J Invasive Cardiol (2005) 1.52
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome. Int J Cardiol (2013) 1.52
Thrombus aspiration without additional ballooning or stenting to treat selected patients with ST-elevation myocardial infarction. J Invasive Cardiol (2010) 1.51
Operator radiation exposure during percutaneous coronary procedures through the left or right radial approach: the TALENT dosimetric substudy. Circ Cardiovasc Interv (2011) 1.49
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol (2006) 1.48
Pooled estimates of immediate and late outcome of mitral valve surgery in octogenarians: a meta-analysis and meta-regression. J Cardiothorac Vasc Anesth (2013) 1.48
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures. Am Heart J (2012) 1.48
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC Cardiovasc Interv (2008) 1.47
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol (2002) 1.46
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). JACC Cardiovasc Interv (2013) 1.46
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry. Catheter Cardiovasc Interv (2009) 1.45
Safety and efficacy of the percutaneous radial artery approach for coronary angiography and angioplasty in the elderly. J Invasive Cardiol (2005) 1.45
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI. J Invasive Cardiol (2008) 1.44
Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: six-year clinical follow-up of the GISSOC trial. J Am Coll Cardiol (2003) 1.43
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry. J Invasive Cardiol (2011) 1.42
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. Am J Med (2011) 1.42
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy. Thromb Haemost (2012) 1.42
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy. Catheter Cardiovasc Interv (2013) 1.42
Implications of new ESC/EACTS guidelines on myocardial revascularisation for patients with multi-vessel coronary artery disease. Eur J Cardiothorac Surg (2011) 1.41
Numbers needed to treat (lives!) and numbers needed to save (money). EuroIntervention (2013) 1.41
Feasibility of complex coronary and peripheral interventions by trans-radial approach using large sheaths. Catheter Cardiovasc Interv (2011) 1.41
Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study. Catheter Cardiovasc Interv (2012) 1.41
On the current epidemic outburst of meta-analytic rage in interventional cardiology. EuroIntervention (2009) 1.40
Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions. J Invasive Cardiol (2007) 1.40
Percutaneous removal of an embolized port catheter: description of a new coaxial recovery technique including a case-report. Catheter Cardiovasc Interv (2008) 1.40
A third generation of ascending aorta Dacron graft: preliminary experience. Ann Thorac Surg (2008) 1.40
Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry. J Invasive Cardiol (2009) 1.39
Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients. Catheter Cardiovasc Interv (2013) 1.39
Patients with in-stent restenosis have an increased risk of mid-term venous graft failure. Ann Thorac Surg (2006) 1.38
Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease. Catheter Cardiovasc Interv (2011) 1.37
Direct coronary stenting by transradial approach: rationale and technical issues. Catheter Cardiovasc Interv (2004) 1.37
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. Am Heart J (2011) 1.31
Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol (2005) 1.27
Long-term results of the radial artery used for myocardial revascularization. Circulation (2003) 1.20
Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Catheter Cardiovasc Interv (2007) 1.20
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest (2014) 1.20
How many leads through persistent left superior vein cava and coronary sinus? J Electrocardiol (2010) 1.19
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail (2009) 1.17
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? J Am Soc Echocardiogr (2007) 1.15
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol (2005) 1.13
Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size. Int J Cardiol (2005) 1.12
Transbrachial intraaortic balloon pumping in severe peripheral atherosclerosis. Ann Thorac Surg (2007) 1.10
The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail (2009) 1.08
Cardiac resynchronization therapy or sequential pacing in failing Mustard? J Electrocardiol (2010) 1.08
Stent Type and Risk of Late Cerebral Events After Carotid Artery Stenting. J Am Coll Cardiol (2015) 1.05
Spontaneous dissections of coronary arteries and acute coronary syndromes: rationale and design of the DISCOVERY, a multicenter prospective registry with a case-control group. J Cardiovasc Med (Hagerstown) (2009) 1.05
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv (2012) 1.05
Endoscopic dilation of benign colorectal anastomotic stricture after low anterior resection: A prospective comparison study of two balloon types. Gastrointest Endosc (2004) 1.03
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail (2010) 1.02
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond) (2013) 1.02
Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J (2005) 1.01
Comparison of the feasibility and effectiveness of transradial coronary angiography via right versus left radial artery approaches (from the PREVAIL Study). Am J Cardiol (2012) 1.01
Drug-eluting stent safety: findings from preclinical studies. Expert Rev Cardiovasc Ther (2008) 1.00
Evaluation of the "learning curve" for left and right radial approach during percutaneous coronary procedures. Am J Cardiol (2011) 0.99
Comparison of assessment of native coronary arteries by standard versus three-dimensional coronary angiography. Am J Cardiol (2008) 0.98
Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction. Int J Cardiol (2005) 0.97
Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J (2005) 0.97
Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials. Int J Cardiol (2007) 0.97
Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation (2005) 0.96
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med (Hagerstown) (2008) 0.96
Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis (2007) 0.95
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol (2009) 0.95
Polytetrafluoroethylene stent deployment for a left anterior descending coronary aneurysm complicated by late acute anterior myocardial infarction. Circulation (2005) 0.92
Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace (2004) 0.92
Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms. Endocrinology (2007) 0.92